Literature DB >> 9366440

Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids.

M Geissler1, A Gesien, J R Wands.   

Abstract

Chronic hepatitis C viral (HCV) infection is a major clinical problem in alcoholics with liver disease and may result from ethanol effects on the host immune response. To experimentally assess such effects, the DNA-based immunization approach was used to produce humoral and cellular immune responses against the HCV core protein in mice. Mice were fed an ethanol or isocaloric pair-fed control liquid diet followed by immunizations with HCV core DNA-expressing constructs. Chronic ethanol feeding was found to inhibit Th cell and CTL activities and substantially reduced cytokine secretion as well. In addition, a switch from Th1 to Th0 subtype was observed in proliferating CD4+ T cells derived from chronic ethanol-fed mice. These immunosuppressive effects were directly due to ethanol since crossover experiments to an isocaloric control diet restored the defects in cellular immunity. Furthermore, we determined if coadministration of an IL-2 or GM-CSF DNA expression plasmid with a plasmid expressing the HCV core protein (pHCV2-2) would reverse the inhibitory effects of chronic ethanol feeding on cellular immune responses. Coimmunization of chronic ethanol-fed mice with either IL-2 or GM-CSF expression plasmids restored cellular immunity and induced CD4+ inflammatory T cell and CD8+ CTL responses comparable with control mice immunized with pHCV2-2 alone. These studies provide evidence of how chronic ethanol feeding may effect cellular immune responses to a viral structural protein in the context of genetic immunization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366440

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

Review 1.  Immunopathogenesis of viral hepatitis.

Authors:  M U Mondelli
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Heavy drinking greatly increases the risk of cirrhosis in patients with HCV hepatitis.

Authors:  C P Day
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

3.  Mechanisms by which chronic ethanol feeding limits the ability of dendritic cells to stimulate T-cell proliferation.

Authors:  Ji Fan; Michelle R Edsen-Moore; Lucas E Turner; Robert T Cook; Kevin L Legge; Thomas J Waldschmidt; Annette J Schlueter
Journal:  Alcohol Clin Exp Res       Date:  2010-10-06       Impact factor: 3.455

4.  Moderate alcohol consumption enhances vaccine-induced responses in rhesus macaques.

Authors:  I Messaoudi; M Asquith; F Engelmann; B Park; M Brown; A Rau; J Shaw; K A Grant
Journal:  Vaccine       Date:  2013-11-06       Impact factor: 3.641

5.  Chronic alcohol-induced liver disease inhibits dendritic cell function.

Authors:  Dechun Feng; Ahmet Eken; Vivian Ortiz; Jack R Wands
Journal:  Liver Int       Date:  2011-03-21       Impact factor: 5.828

6.  Ethanol inhibits antigen presentation by dendritic cells.

Authors:  Ahmet Eken; Vivian Ortiz; Jack R Wands
Journal:  Clin Vaccine Immunol       Date:  2011-05-11

Review 7.  Hepatitis C virus and ethanol alter antigen presentation in liver cells.

Authors:  Natalia A Osna
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

8.  Chronic ethanol diet increases regulatory T-cell activity and inhibits hepatitis C virus core-specific cellular immune responses in mice.

Authors:  Vivian Ortiz; Jack R Wands
Journal:  Hepatol Res       Date:  2013-07-04       Impact factor: 4.288

9.  Stable expression of Hantavirus H8205 strain G1/IL-2 gene and immune protection of the fusion gene.

Authors:  Ying Xiong; Yuan Yuan; Min Jia; Bing Yu; Hanju Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-04

Review 10.  Hepatitis C virus and alcohol.

Authors:  Larry Siu; Julie Foont; Jack R Wands
Journal:  Semin Liver Dis       Date:  2009-04-22       Impact factor: 6.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.